Heller M, Henrici C, Buttner J, Leube S, et al. SARS-CoV-2 Neutralizing Antibody Therapies: Early retrospective cohort study of 26 hospitalized patients treated with Bamlanivimab or Casirivimab/Imdevimab. Int J Infect Dis 2023 Jan 20:S1201-9712(23)00012.
PMID: 36690138